Popular Categories
Call for Papers: Prevention and Treatment of Opioid Overdose and Opioid-Use Disorders
Addictive Behaviors is now accepting submissions for a special issue, Prevention and Treatment of Opioid Overdose and Opioid-Use...
Apr 17, 2017 | Kim Rodgers
Now Available! Winter 2017 NACCHO Exchange: Local Public Health vs. America’s Opioid...
The Winter 2017 issue of NACCHO Exchange, “On the Frontlines: Local Public Health versus America’s Opioid Epidemic,” is...
Mar 07, 2017 | Kim Rodgers
State of the Opioid Epidemic: Local Public Health as the First Line of Defense
This week, January 23–29, 2017, marks National Drug and Alcohol Facts Week. Although this annual observance is aimed at engaging teens...
Jan 27, 2017 | Kim Rodgers
MMWR – Increases in Drug and Opioid-Involved Overdose Deaths — United States,...
From 2014 to 2015, the death rate from synthetic opioids other than methadone, which includes fentanyl, increased by 72.2%, and heroin...
Jan 06, 2017 | Kim Rodgers
Reflections from the 2016 Harm Reduction Conference
Harm reduction is an important movement that started thirty years ago in the early days of the HIV epidemic, when people who inject...
Dec 06, 2016 | Kim Rodgers
Now Available: CDC Vital Signs Report on HIV and Injection Drug Use
The Centers for Disease Control and Prevention (CDC) just announced the release of Vital Signs: Trends in HIV Diagnoses, Risk...
Nov 29, 2016 | Kim Rodgers
Opioid Epidemic in Rural America
The prevalence of substance abuse disorders in the U.S. has increased dramatically in the past 15 years with catastrophic...
Sep 13, 2016 | Kim Rodgers
HHS Releases Implementation Guidance to Support Syringe Services Programs
The U.S. Department of Health and Human Services (HHS) has issued guidance regarding the use of Federal funds to implement or expand...
Mar 29, 2016 | Alyssa Kitlas
Narcan® (Naloxone Hydrochloride) Nasal Spray Approved By U.S. Food and Drug...
The FDA approved NARCAN® (naloxone hydrochloride) Nasal Spray for the emergency treatment of known or suspected opioid overdose. In...
Nov 27, 2015 | Alyssa Kitlas
Call for Papers: Prevention and Treatment of Opioid Overdose and Opioid-Use DisordersAddictive Behaviors is now accepting submissions for a special issue, Prevention and Treatment of Opioid Overdose and Opioid-Use Disorders. Papers may include epidemiological, laboratory-based, or community-based research on prevention and/or treatment of opioid overdose, misuse of opioids (prescribed or illicit), and opioid-use disorders. Specific topics of interest include: Community-based... Apr 17, 2017 | Kim Rodgers |
Now Available! Winter 2017 NACCHO Exchange: Local Public Health vs. America’s Opioid EpidemicThe Winter 2017 issue of NACCHO Exchange, “On the Frontlines: Local Public Health versus America’s Opioid Epidemic,” is now available for free download in the NACCHO Bookstore. Opioid addiction and misuse have affected inner city, suburban, and rural communities, challenging America’s perceptions of what substance use disorders look like, where they occur, and who they affect. This... Mar 07, 2017 | Kim Rodgers |
State of the Opioid Epidemic: Local Public Health as the First Line of DefenseThis week, January 23–29, 2017, marks National Drug and Alcohol Facts Week. Although this annual observance is aimed at engaging teens in events that debunk myths about drugs and alcohol, NACCHO is instead taking this opportunity to provide a sneak-peek into our Winter NACCHO Exchange issue, “On the Frontlines: Local Public Health versus America’s Opioid […] Jan 27, 2017 | Kim Rodgers |
MMWR – Increases in Drug and Opioid-Involved Overdose Deaths — United States, 2010–2015From 2014 to 2015, the death rate from synthetic opioids other than methadone, which includes fentanyl, increased by 72.2%, and heroin death rates increased by 20.6%. Rates of death involving heroin and synthetic opioids other than methadone increased across all demographic groups, regions, and in numerous states. Natural/semisynthetic opioid death rates increased by 2.6%, whereas, […] Jan 06, 2017 | Kim Rodgers |
Reflections from the 2016 Harm Reduction ConferenceHarm reduction is an important movement that started thirty years ago in the early days of the HIV epidemic, when people who inject drugs and their sex partners were dying of AIDS at alarming rates. Harm reduction is a framework for meeting people where they are at and reducing the negative consequences of drug use. […] Dec 06, 2016 | Kim Rodgers |
Now Available: CDC Vital Signs Report on HIV and Injection Drug UseThe Centers for Disease Control and Prevention (CDC) just announced the release of Vital Signs: Trends in HIV Diagnoses, Risk Behaviors, and Prevention Among Persons Who Inject Drugs, a new report on HIV, injection drug use, and the role of syringe services programs (SSPs) in prevention. Persons who inject drugs (PWID) are at high risk for HIV […] Nov 29, 2016 | Kim Rodgers |
Opioid Epidemic in Rural AmericaThe prevalence of substance abuse disorders in the U.S. has increased dramatically in the past 15 years with catastrophic consequences, especially in rural regions. Deaths and injuries from illegal opioid and heroin use are more prevalent in rural states, and death from opioid overdose is 45 percent higher in rural regions than urban areas. National […] Sep 13, 2016 | Kim Rodgers |
HHS Releases Implementation Guidance to Support Syringe Services ProgramsThe U.S. Department of Health and Human Services (HHS) has issued guidance regarding the use of Federal funds to implement or expand syringe services programs (SSPs) for people who inject drugs. The guidance was designed for programs directly funded by HHS interested in implementing or expanding SSPs. SSPs include the provision of sterile needles, syringes, […] Mar 29, 2016 | Alyssa Kitlas |
Narcan® (Naloxone Hydrochloride) Nasal Spray Approved By U.S. Food and Drug AdministrationThe FDA approved NARCAN® (naloxone hydrochloride) Nasal Spray for the emergency treatment of known or suspected opioid overdose. In 2013, opioid overdose related deaths claimed over 24,500 lives and this number continues to grow. NARCAN Nasal Spray, a ready-to-use, needle-free device, delivers a 4 mg dose of naloxone in a single 0.1 ml nasal spray. NARCAN […] Nov 27, 2015 | Alyssa Kitlas |
Subscribe Today
Sign Up for the E-mail Digests
Create an account or login to MyNACCHO and go to "My Subscriptions."
SUBSCRIBE NOW
